Eli Lilly seeks FDA approval for COVID-19 drug
U.S. drugmaker Eli Lilly said is it seeking emergency use authorization from the FDA for its experimental COVID-19 antibody monotherapy and plans to pursue a similar approval for a combination therapy with two of its antibody drugs next month.
Comentarios
Publicar un comentario
Leave a comment. Thanks!
Comentarios de Facebook